DayTwo provides personalized nutrition and actionable insights that allow consumers to live healthier and maintain normal blood sugar levels. DayTwo does this through DNA sequencing of the gut microbiome – the vast collection of bacteria, which is as unique to each individual as their fingerprints. DayTwo leverages the scientific and evidence-based understanding of the microbiome so consumers may take practical and immediate steps to improve their own health and wellbeing.

The DayTwo service is based on six years of clinical research conducted by Professors Eran Segal and Dr. Eran Elinav from the Weizmann Institute of Science in Israel. Dr. Segal’s and Dr. Elinav’s research has been funded solely by the Weizmann Institute of Science and upon its completion, the research technology was licensed exclusively to DayTwo. The clincial research results on which our product and service is based have been published in the Nature, The Cell, Cell Metabolism.